Rare diseases
Investigational molecules
Locations
Back to Germany3 clinical trials in Garmisch-Partenkirchen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Fibrodysplasia Ossificans Progressiva (FOP), evaluating new therapeutic approaches to manage abnormal bone formation. The trials aim to assess safety and effectiveness of novel treatments for this rare genetic condition.
Studies are investigating targeted therapies to potentially halt disease progression.
Long-term research into eosinophilic esophagitis, examining innovative treatments for this chronic allergic inflammatory condition. The trials focus on evaluating extended safety profiles of new therapeutic agents.
Research aims to improve long-term management options for patients.
Advanced studies in breast cancer and chronic lymphocytic leukemia, particularly focusing on hormone receptor-positive HER2-negative cases and high-risk CLL variants. Trials evaluate combination therapies and targeted treatments.
Research emphasizes personalized treatment approaches for specific cancer subtypes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
